Molbio Diagnostics received international recognition at the 77th World Health Assembly in Geneva for its pioneering Truenat technology. Lauded by global health leaders, including the Global Fund and WHO representatives, Truenat was highlighted as a model innovation for expanding access to rapid, point-of-care diagnostics. Designed to operate in remote and resource-limited settings, Truenat empowers early and accurate disease detection, strengthening global efforts against infectious and non-communicable diseases. Molbio’s work continues to drive the decentralization and democratization of healthcare worldwide.
